Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Non Operating Income (2009 - 2026)

Updated

Regeneron Pharmaceuticals' Non Operating Income was $234.3 million in Q2 2026, down 46.7% from $439.2 million a year earlier but up 24.4% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Non Operating Income (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Regeneron Pharmaceuticals' Non Operating Income was $1.32 billion through Jun 30, 2026, up 28.0% year-over-year; for FY2025, it came in at $1.65 billion, up 109.4% from FY2024.

  • Non Operating Income has now increased for three consecutive years, with a five-year compound annual growth rate of 47.9% (FY2020 to FY2025).
  • In earlier years, Non Operating Income was $789.2 million in FY2024 (+418.5%), $152.2 million in FY2023 (+26.9%), $119.9 million in FY2022 (-68.4%) and $379 million in FY2021 (+62.1%).
  • Quarterly Non Operating Income has moved between -$197.4 million (Q1 2022) and $736.5 million (Q3 2025) over five years.
  • Compared with a year earlier, Non Operating Income was higher in 1 of the last four quarters, with growth averaging 6.8%.
  • Per Business Quant data, REGN's Non Operating Income in the three quarters before Q2 2026 was $188.3 million (Q1 2026), $163.8 million (Q4 2025) and $736.5 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn -
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 387.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 234.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 234.30 Mn
Mar 31, 2026 188.30 Mn
Dec 31, 2025 163.80 Mn
Sep 30, 2025 736.50 Mn
Jun 30, 2025 439.20 Mn
Mar 31, 2025 313.30 Mn
Dec 31, 2024 -32.10 Mn
Sep 30, 2024 313.50 Mn
Jun 30, 2024 558.50 Mn
Mar 31, 2024 -50.70 Mn
Dec 31, 2023 174.70 Mn
Sep 30, 2023 -200,000.00
Jun 30, 2023 66.40 Mn
Mar 31, 2023 -88.70 Mn
Dec 31, 2022 177.90 Mn
Sep 30, 2022 286.10 Mn
Jun 30, 2022 -146.70 Mn
Mar 31, 2022 -197.40 Mn
Dec 31, 2021 -136.30 Mn
Sep 30, 2021 -30.60 Mn
API Access

Regeneron Pharmaceuticals Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=REGN&period=max&api_key=YOUR_API_KEY